n this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore cravings and the role they play in metabolic dysfunction.

If you watch some drug company commercials these days, you’d think cravings are the culprit for obesity. In reality, they are just a symptom of a deeper metabolic problem.

This episode of Fat Science uncovers why this oversimplification is not just misleading but harmful to those struggling with metabolic dysfunction.

Join us as we explore the science behind cravings, debunk common myths and highlight the importance of understanding your metabolic health.

Key Takeaways:

Not Just an Overeating Problem: Learn why targeting cravings alone is not the answer to managing weight and metabolic health.

Metabolic Dysfunction Explained: Discover how metabolic dysfunction manifests in various forms, such as irregular appetite signals, and why addressing the root cause is crucial for effective treatment.

The Role of Medications: Dr. Cooper breaks down commonly-prescribed medications like Contrave, Qsymia, and Saxenda—explaining their true function in strengthening metabolic pathways rather than merely suppressing cravings.

Misleading Advertising: Understand the detrimental effects of current advertising campaigns that focus on willpower and cravings and how they perpetuate weight stigma and misinformation.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore one of the most contentious topics in the world of health and fitness: the definition and measurement of fat.

BMI (Body Mass Index) has long been the standard, but recent studies have called its efficacy into question.

Dr. Cooper reveals why BMI can be a flawed indicator of health, exploring alternate measurements like waist circumference and body composition while discussing their limitations and potential misuses.

This episode highlights the real issue: identifying and treating metabolic dysfunction and achieving true health beyond just numbers on a scale or tape measure.

Key Takeaways:

BMI: A Flawed Metric? Dr. Cooper reveals the limitations of BMI. She shares intriguing insights into how factors like muscle mass and gender-specific body composition can skew BMI readings and recounts fascinating stories from her career, including a case where an Olympic athlete was classified as obese purely based on BMI.

The Lancet's Insight. The team discusses a recent paper by the esteemed Lancet Commission, which argues for de-emphasizing BMI in favor of other health indicators. They dive into the importance of looking at the complete clinical picture, including blood sugar swings, energy levels, and more.

Anecdotes and Real-life Experiences. Andrea Taylor shares her journey of struggling with various diets until discovering metabolic dysfunction as the root problem.

Insurance and Medical Ethics. Discover the ethical dilemmas of using BMI for decisions on insurance coverage and medical treatments. Mark brings attention to startling cases where statistically healthy individuals were denied life insurance based on high BMI.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore five New Year’s resolutions you can make (and not break) for a healthier 2025.

The conversation shifts away from unattainable goals and toward practical steps for enhancing overall well-being in the new year.

Key Takeaways:

1. Address Metabolic Syndrome
   If you suspect you have metabolic syndrome, 2025 is the year to take action. Dr. Cooper explains how to identify and address it with testing and medical guidance.
2. Health Over Beach Body
   Shift the focus from attaining a "beach body" to improving your overall health. Andrea discusses the importance of self-acceptance and the harm of societal pressures.
3. Don't Diet
   Commit to not dieting. Dr. Cooper emphasizes the metabolic dangers of calorie restriction and the benefits of balanced nutrition.
4. Get Enough Sleep
   Quality sleep is crucial for metabolic health. Learn why 7-9 hours of sleep and timing your sleep cycles matter.
5. Be Kind to Yourself
   Embrace self-love and physiologic intuition. Andrea shares how this has transformed her relationship with food and body image.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright field questions from listeners. Throughout the show, our hosts highlight the importance of compassionate, science-based medical care and underscore the significance of finding healthcare providers who address metabolic issues as medical, not lifestyle, concerns.

Among the topics addressed:

1. • Statins & Weight Gain: We discuss concerns about the relationship between statin use and weight gain, addressing fears of indefinite use and potential side effects related to diabetes risk.
   • “Normal” Lab Results Despite Symptoms: Kate questions why lab results might appear normal while still experiencing symptoms of metabolic dysfunction.
   • Gut Health Impact on Metabolism: We cover the link between gut health and metabolic dysfunction, emphasizing the importance of gut motility and microbiome balance.
   • Pregnancy and Metabolic Changes: Dr. Cooper discusses how pregnancy can impact metabolic function, with some women experiencing improvements while others may face challenges like gestational diabetes.
   • Genetics: Dr. Emily Cooper delves into how metabolic disorders can be transferred to offspring, noting that these issues can be triggered and amplified with each pregnancy.
   • Barbara inquires about the safety of GLP1 medications given a history of papillary thyroid cancer.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright take a comprehensive look at the current FDA-approved medications designed to treat metabolic dysfunction and what may be approved next.

Dr. Cooper discusses the range of factors that determine whether these essential drugs are available for those who need them. Government approval, drug company strategies and insurance company policies all play a role.

Key Takeaways:

• Pharmaceutical Approval Process:
• • Pharmaceutical companies typically seek FDA approval for one drug indication at a time due to the high costs and extensive trial requirements.
  • Approval for obesity drugs is more stringent than for diabetes, involving costly and rigorous trials.
• Rebranding Drugs for Accessibility:
• • Drugs like Liraglutide (originally Victoza for diabetes) are rebranded as Saxenda for obesity to bypass insurance coverage issues.
  • However, rebranding can create coverage gaps for weight-loss purposes, leaving some patients without access.
• Insurance Coverage Challenges:
• • Insurance companies often limit coverage for these medications unless a patient has a diagnosed condition like type 2 diabetes.
  • Preventative benefits of metabolic medications are frequently overlooked by insurers, limiting broader access.
• Risks with Compounded Medications:
• • Compounding pharmacies are creating untested versions of GLP-1 drugs to address affordability and shortages, raising safety concerns.
• Future Developments in Metabolic Meds:
• • New potential drugs, such as a dual hormone agonist and high-dose semaglutide as a daily pill, show promise in improving metabolic health and accessibility.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright reveal how metabolic lab tests are crucial in diagnosing, understanding and treating metabolic dysfunction.

Key Takeaways:

• Metabolic Functions:
  Understanding blood markers like glucose, insulin, and cholesterol offers in-depth knowledge about overall health.
• Metabolic Syndrome:
  Defined by issues like pre-diabetes, high blood pressure, and cholesterol problems, increasing the risk of severe health events.
• Lab Testing:
  Routine testing every 3-4 months for monitoring and adjusting treatments. Dr. Cooper also reveals which labs are key to diagnosing metabolic dysfunction.
• Comprehensive Assessment:
  Insights into advanced tests for detailed metabolic evaluation.
• Genetic Awareness:
  Highlighting the role of genetics in health risks and the importance of preventive measures.

Personal Stories & Practical Advice:

• Andrea shares her journey and health improvements through dedicated metabolic management.
• Mark discusses the transformative impact of metabolic treatment, how it sometimes takes years to improve metabolic markers and the importance of consistency when taking metabolic meds.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright tackle the challenges of maintaining metabolic health during the holiday season. Dr. Cooper emphasizes the importance of keeping a regular routine to manage stress and avoid metabolic disruptions. The team shares practical advice for navigating family gatherings and enjoying the holidays without compromising your health.

Key Takeaways:

• Society's excessive focus on weight and appearance can be harmful; value shouldn't be based on physical changes.
• GLP1 medications need to be introduced gradually; skipping meals while on them can disrupt metabolism.
• Avoid contentious family discussions about weight, diet, and metabolism to prevent stress.
• Tryptophan in turkey is not the cause of post-meal drowsiness; overeating likely is.
• Stick to regular sleep and eating patterns to manage stress and maintain metabolic health.
• Extreme exercise during holidays can raise cortisol levels; maintaining a consistent routine is better.
• Family traditions and memories are important; a balanced approach to holiday eating can improve your overall experience.

Personal Stories & Practical Advice:

• Andrea discusses her family's tradition of holiday baking and her evolving relationship with food.
• Mark shares memories of Scandinavian holiday foods and the comfort he finds in holiday eating traditions.
• Dr. Cooper advises on balancing food intake and avoiding overemphasis on weight loss during holidays.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, hosts Dr. Emily Cooper, Andrea Taylor, and Mark Wright explore the compelling and urgent topic of COVID-19's impact on metabolic health.

COVID-19 has introduced a serious new layer of complexity because it can exacerbate existing conditions like diabetes, obesity, cardiovascular and thyroid disease.

The latest data reveal a shocking statistic—the risk of developing diabetes can increase by up to 40 percent after a COVID infection.

So what should we know about these risks, and how can scientific insight help us navigate this new terrain?

Key Discussion Points:

• Early Data and Predictions: Insights from Dr. Cooper's clinic, supported by the Diabesity Institute, which identified early links between COVID-19 and metabolic disease risk.
• Real-World Impacts: The clinic’s database comprising around 2,500 patients with more than 10 years of data, which showcases the regression of metabolic health progress post-pandemic.
• Public Health: The importance of vaccinations, continuous COVID monitoring, and preventive practices to mitigate these risks.
• Metabolic Meds: The role of medications like Metformin and Ozempic in managing complications from pre-diabetes and diabetes, particularly during COVID.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope.

Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.